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1. INTROBUCTIQN 
Amanradine (I-aminoadamantanc) is an FDA licens- 
ed anti-influenza A drug 111 and a treatment for Parkin- 
son’s disease [2]. Tromantadine (N-1-adamantyl-N- 
[2-(dimethylamino)cchoxy~aceramide-hydrochlaride) is 
an amantadinc derivative which inhibits early and late 
steps in herpes simplex virus replication including 
penetration 131, HSV induced syncytia formation and 
HSV glycopratein processing [4]. Amidine D295 
(cyclohexylcarboximidamide-(~-benzyl)hydrochloride) 
has similar anti-HSV activities but is less potent than 
tromantadine (unpublished ata), 
Amantadine and other lipophilic amines can inhibit 
infection by influenza A [I] as well as vesicular 
stomatitis virus, Semliki Forest and other viruses IS]. 
Their antiviral activity and ability to inhibit endocytic 
uptake of iigands have been attributed to their 
acidophilic/lysosomotropic properties f 1,6]. Many 
lipophilic amines, including amantadine and its 
derivative, tromantadine, can also interact with mem- 
branes to stabilize their structure and prevent fusion 
processes [7,83. 
Some hydrophobic amines and di- or polybasic 
amines interact with, and affect the function of clathrin 
and clathrin coated vesicles. CCV stabilization [9] and 
clathrin polymerization [IO, II] can be promoted by di- 
or polybasic amines, e.g. spermine [9,1 l], hydrophobic 
aromatic amines, e,g. phenothiazines, chloroquin and 
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internalization 
monodansylcadavcrinc. WC identified another ac- 
tivity for amantadine and tromantadinc which could 
contribute co their ability to inhibit ligand uptake. 
2. RESULTS AND DISCUSSIOIL‘ 
2.1. Isolation of coated vesicles 
CCV were isolated from pig brains and separated by 
ultracentrifugation on sucrose density gradients accor- 
ding to Keen et al, [14]. The purified coated vesicles 
were collected and stored at 4°C in the final 5% sucrose 
fraction of the preparation. Samples were not frozen 
and were used within one week of isolation to minimize 
loss of integrity of the coated vesicles. All operations 
were performed at 4°C using MES buffer (0.1 M MES 
[2-(ZV-morpholino)ethane sulfonic acid] pM 6.5, 1 mM 
EGTA, 0.5 mM MgCl2 and 0.02% sodium azide, unless 
noted. 
The CCV fraction and samples were characterized by 
sodium dodecyl sulfate polyacrylamide gei elec- 
trophoresis on reducing 7.5go gels [15] and by electron 
microscopy. The predominant polypeptide in CCV 
fractions was clathrin with a molecular mass of 180000 
Da but other CCV proteins at 100000, 50000, 36000 
and 30000 Da were also detected. Intact CCV were 
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Aliqusfr of clathrin-coafed vexiclela contwining 45-60 
&ml prarein were pelletfed 611 li3OOMix~ for I h anti 
rcellspencfccl gently in citkrer M&S Irulfrtr, pItE 6.5, dif- 
ferenf conecnfrnfions at+ ctlc feaf sampound in MES 
buffcr or 0.5 M Tris-HCI at pi3 74 and then incubated 
for 30 min af 2S°C or 37T. Studier were performed -at 
pH 6-5 fa maximiae CCV xtsbilicy and fflinimixe CCV 
aggregation [9,11,17,1 W]. 
The extent of dissociation sf CCV wbs dekrmlned by 
cvalurttisn of the rekcive elnthrin concentratiana af 
supernaranr and pellet nnmplcs (13QB00 x g for 30 min), 
8s determined by denritomerrie scan of the Coomorssic 
blue-stained band corresponding co elarhrin an the 
SDS-PAGE. The densiromefric readings were linenr for 
protein conccnt.ration within the clnrhrin conccntrarion 
ranges used in this study, Rcgrc,wwaivc samples 
following each treatment were examined by electron 
microscopy to evnluafc ttle coafed vesicle samples for 
dissociation and clumping. 
Whereas no clachrin release co the supcrnatant was 
observed after storage for as long as 3 days at 4OC, a 
30.min incubation at 25°C caused release of 28% (SEM 
(standard error of sample mean) 2.4, II= 3) of the 
clathrin to the supernacanr. Incubation of the CCV 
sample for 30 min at 37°C promoted dissociation of 
41% (SEM 1.2, n =4) OF the clarhrin from the CCV. 
Maximal release of clathrin from the CCV could be ob- 
tained by incubation of CCV at 37.5”C in 0.5 M Tris- 
I-ICI PI-I 7,O at 37.5’C [14]. The Tris treatment caused 
release of 89.6% (SEM 1.5, )I = 4) of the clarhrin from 
CCV. The lack of basket-like structures and intact 
clathrin coats on vesicles by eIectron microscopy cor- 
roborated the disruption of the CCV. 
2.3. Treatment of CCV with tromuntadine, mt~n- 
&dine, chloroyuin, a&dine 295, or mmo- 
dunsylcaduverine 
CCV were incubated with 0,O. 1, 1.0 or 10 mM aman- 
tadine (Sigma, St, Louis, MO), tromantadine (Merz, 
Frankfurt), amidine D295 (Merz, Frankfurt), chloro- 
quin (Sigma, St. Louis, MO) or monodansylcadaverine 
(Sigma, St. Louis, MO) in MES buffer at PI-I 6.5 for 30 
min at 37’C. 
Incubation of the CCV suspension in 10 mM aman- 
t&dine, amidine 295 or monodansylcadaverine; 1 .O mM 
tromantadine or 0.1 mM chloroquin significantly (5% 
level of significance as substantiated by Tukey Test 
statistical analysis [I9]) reduced the release of clathrin 
%Qcllc~ ekhrln 
info the supcrnatanf hacfion (Table I) (Fig, 1). The elm 
fcccts of the treatments on CCV were corroborated by 
qurdifative electron microscopic obscrvnrion. A lrigker 
praporrisn BP intuct, Coated vesicles, GS compared to 
control and Tris-treated samples, was observed follow- 
ing incubation with the effective concentrations of 
drug, Although both rhc CCV and polymerized clathrin 
structures would be expected to precipitate, CCV were 
the predominant structure seen in electron micm- 
graphs, Clumping, which would increase non-specific 
pelleting of CCV and confound the result, was not 
observed. The greater CCV-stabilizing activity of 
chloroquin corresponds with its reported activity on 
clathrin polymerization and stabilization [lo], The 
ability of amantadinc, tromantadinc and amidine D295 
to stabilize CCV adds to the list of structural deter- 
minants which provide this activity. 
The decrease in the levels of soluble clathrin follow- 
ing treatment of clathrin-coated vesicles with these 
Table 1 
Inhibirion of clsthrin release from clathrin-coated vesicles. 
Drug conr;cntration 
Percent clathrin in pellet’ 
0 0.1 mM 1,O mM 10 mM 
Amantadine 58 5.8 62 72’ 
Amidinc D295 59 59 64 752 
Tromantadinc 59 61 802 8lL 
Chloroquin 58 712 822 872 
Monodansylcadaverinc’ 39 36 47 711 
’ Purified CCV were incubated in MES buffer or with different 
concentrations of drug for 30 min at 37’C, centrifuged and the 
supernatant and pellet analyzed by SDS-PAGE. The relative clathrin 
concentrations were determined from densitometric traces of the 
160 kDa polypeptide band. The SEM (standard error of sample 
mean) was less than 2 for all samples. 
’ Significantly different from control as determined by Tukey test. 
.r Experiment performed independent of others. 
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